跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
注射用右雷佐生 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Dexrazoxane for Injection
Approved
化学药品
Dexrazoxane for Injection
GLAND PHARMA LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Feb 7, 2023
Approval ID
feabe96736a276b8
Company
GLAND PHARMA LIMITED
Type
化学药品
Approval Details
Approval Id
feabe96736a276b8
Approval Number
国药准字HJ20233122
Generic Name
注射用右雷佐生
Generic Name En
Dexrazoxane for Injection
Drug Type
化学药品
Dosage Form
注射剂
Strength
500mg
Reg Date
2023-02-07
Expired Date
2028-02-06
Company Name
GLAND PHARMA LIMITED
Production Company Name
GLAND PHARMA LIMITED
Company Detail Path
/organization/gland-pharma-limited
Production Company Detail Path
/organization/gland-pharma-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 7, 2023
Approval ID
feabe96736a276b8
Type
化学药品
Back to NMPA Approvals